Ignite Creation Date:
2024-05-05 @ 4:48 PM
Last Modification Date:
2024-10-26 @ 9:24 AM
Study NCT ID:
NCT00314613
Status:
TERMINATED
Last Update Posted:
2017-12-02
First Post:
2006-04-12
Brief Title:
Functional Brain Imaging and Employment in First-Episode Psychotic Patients Treated With Risperdal
Sponsor:
Duke University
Organization:
Duke University
Study Overview
Official Title:
Functional Brain Imaging and Employment in First-Episode Psychotic Patients Treated With Risperdal
Status:
TERMINATED
Status Verified Date:
2010-05
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
Assured treatment with Risperal CONSTA will provide first-episode patients who have a greater potential for therapeutic response with their best opportunity for continued improvement in cognitive function beyond three months of treatment
Detailed Description:
First episode patients have a greater potential for therapeutic response than multi-episode patients and many of them also havea great desire to rejoin the workforce Unfortunately first episode patients become non-compliant or intermittently compliant with prescribed antipsychotic treatment at least as frequently as multi-episode patients We believe that assured treatment with Risperal CONTSTA will provide first episode patients wiwth their best opporutnity for continued improvement in cognitive function beyond 3 months of treatment and that improvements in cognitive function will be associated with a greater likelihood of employment real-world outcomes such as independent living as well as measures of brain function
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None
Secondary IDs
| Secondary ID | Type | Domain | Link |
|---|---|---|---|
| 7858 | None | None | None |
| RIS-NAP-4007 | None | None | None |